Survival Biotech : New Thallion
I still laught at Pepmoron's biotech portefolio; knowing that 80% will die in the coming months if not already... stock price must be near worthless.
New Thallion is going to survive with Tax Arrangement.
Scientific potential was confirmed by ASCO 2009 - KRAS mut is incurable.
4601 is hand made for GBM and Sarbasil has confirmed Partial response for KRAS inhibitor
232 is back and alive trials results have already show significant tumor response at 33% for incurable skin cancer. That's amazing metastatic skin cancer. Now, we go into arbitration and we win the rights to the compound.
Aspergen blackmailing days is over...
All because we have cash to fight a frivilous lawsuit and complete our clinical trials.
Caprion Assets is worth more and more as days goes by.
Trading at below 1/4 of cash value.
This stock is undervalued and ready for market recognition.
Buy, accumulated and wait for Pay Day.